Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pfizer Clostridium difficile vaccine Phase 3 trial in adults ≥50 years
jRCT2080223560Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
Phase 3, randomised, double-blind trial of Clostridium difficile vaccine in Clostridioides difficile colitis (CDI) (2 arms), sponsored by Pfizer. Started Jun 2017; status: completed.
02
Drugs
Clostridium difficile vaccine
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on jRCT2080223560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223560.